Recent Comments

Comment RSS

Toxicology News and Research RSS Feed - Toxicology News and Research

Toxicology is the study of harmful interactions between chemical, physical, or biological agents and biological systems.

USGS researchers examine PAHs and PCBs sources in urban environment

21. November 2009 01:57
Toxic dust: Toxins in coal-tar-based sealcoats in parking lots may be the culprit in contaminated house dust, according to a USGS study. PAHs - or polycyclic aromatic hydrocarbons - are large molecules found in oil, coal and tar deposits, and can have toxic effects. [More]

Posted in: Miscellaneous News

Tags: , , , , , , ,

High blood pressure: A major risk factor for stroke and heart disease

20. November 2009 01:25
Today, Jamieson Laboratories, in partnership with the Victorian Order of Nurses (VON), is holding a one day Blood Pressure Blitz in Toronto's underground PATH system in an effort to educate consumers about the number one risk factor for stroke and a major risk factor of heart disease. [More]

NIEHS grants $13 million for engineered nanomaterials research

20. November 2009 01:17
The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, is increasing its investment in understanding the potential health, safety and environmental issues related to tiny particles that are used in many everyday products such as sunscreens, cosmetics and electronics. The NIEHS will award about $13 million over a two-year period, through the American Recovery and Reinvestment Act, to bolster the NIEHS's ongoing research portfolio in the area of engineered nanomaterials (ENMs). [More]

Posted in: Medical Science News

Tags: , , , , , ,

ScinoPharm receives Potent Compound Safety Certification from SafeBridge Consultants

20. November 2009 01:04
ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), announced that its Tainan facility has received the Potent Compound Safety Certification from SafeBridge(R) Consultants, Inc. [More]

Posted in: Pharmaceutical News

Tags: , ,

Particles released by car brake pads can harm lung cells: Study

19. November 2009 23:18
Real-life particles released by car brake pads can harm lung cells in vitro. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology found that heavy braking, as in an emergency stop, caused the most damage, but normal breaking and even close proximity to a disengaged brake resulted in potentially dangerous cellular stress. [More]

Posted in: Medical Science News | Medical Research News

Tags: , , , ,

ScinoPharm Taiwan receives the SafeBridge Potent Compound Safety Certification

19. November 2009 07:13
SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that ScinoPharm Taiwan Limited in Tainan, Taiwan has met the criteria established under the SafeBridge program for “Potent Compound Safety Certification” and has been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients (“APIs”). [More]

Posted in: Pharmaceutical News

Tags: , , ,

Outdoor smoking areas: A new health hazard

19. November 2009 04:26
Indoor smoking bans have forced smokers at bars and restaurants onto outdoor patios, but a new University of Georgia study in collaboration with the Centers for Disease Control and Prevention suggests that these outdoor smoking areas might be creating a new health hazard. [More]

Posted in: Medical Research News

Tags: , , , , , ,

BioLife Solutions announces that it has been granted a Japanese patent

18. November 2009 07:06
BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that it has been granted a Japanese patent for an application that includes claims related to protecting cells from injury and death caused by cold temperatures used in biopreservation. [More]

Posted in: Medical Patent News

Tags: , ,

Report on complex IP landscape that affects development of human embryonic stem cell products

18. November 2009 04:09
Research and Markets (http://www.researchandmarkets.com/research/a39a10/opportunities_in_h) has announced the addition of the "Opportunities in Human Embryonic Stem Cell (hESCs) Products" report to their offering. [More]

On-going Phase 2b study conducted by Roche of ITMN-191 modified

18. November 2009 03:55
InterMune, Inc. today announced that the on-going Phase 2b study conducted by Roche of ITMN-191 (RG7227) combined with standard of care (SOC) PEGASYS® (peginterferon alfa-2a) and COPEGUS® (ribavirin) in HCV treatment-naive patients has been modified. [More]

Study to test anti-tumor effects of AEOL 10150 initiated

18. November 2009 03:04
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts. [More]

Ore Pharmaceutical Holdings reports financial results and provides operational updates for third quarter 2009

13. November 2009 10:56
Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009. [More]

Study: Coffee might be effective to fight against colon cancer

13. November 2009 03:57
A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. [More]

Posted in: Medical Condition News

Tags: , , , , , , , ,

Gene delivery strategy to help improve muscle mass in patients with degenerative muscle disorders

12. November 2009 00:50
Severe weakness of the quadriceps is a defining feature of several neuromuscular disorders. Researchers at Nationwide Children's Hospital have shown that a gene delivery strategy that produces follistatin - a naturally occurring protein that inhibits myostatin, a growth factor expressed specifically in skeletal muscle - directly to the quadriceps of non-human primates results in long-term gene expression with muscle enhancing effects, including larger muscles with greater strength. [More]

Duke University, Jubilant Organosys sign letter of intent for drug development partnership

11. November 2009 04:42
Duke University and Jubilant Organosys Limited, the largest integrated Custom Research and Manufacturing Services (CRAMS) and leading Drug Discovery and Development Services (DDDS) company in India, through its subsidiary, Jubilant Biosys Limited, today signed a Letter of Intent to develop a multi-faceted partnership that will expedite translation of discoveries by Duke scientists into clinical therapies. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.